-
1
-
-
84892649479
-
Standards of medical care in diabetes-2014
-
American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl 1):S14-80.
-
(2014)
Diabetes Care
, vol.37
, pp. S14-80
-
-
American Diabetes Association1
-
2
-
-
34547224132
-
Short-term variability in measures of glycemia and implications for the classification of diabetes
-
Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007;167:1545-51.
-
(2007)
Arch Intern Med
, vol.167
, pp. 1545-1551
-
-
Selvin, E.1
Crainiceanu, C.M.2
Brancati, F.L.3
Coresh, J.4
-
3
-
-
0037015288
-
Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short- and long-term simvastatin treatment
-
Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002;106:1211-8.
-
(2002)
Circulation
, vol.106
, pp. 1211-1218
-
-
Ceriello, A.1
Taboga, C.2
Tonutti, L.3
Quagliaro, L.4
Piconi, L.5
Bais, B.6
-
4
-
-
0034833888
-
Postprandial blood glucose. American diabetes association
-
American Diabetes Association. Postprandial blood glucose. American diabetes association. Diabetes Care 2001;24:775-8.
-
(2001)
Diabetes Care
, vol.24
, pp. 775-778
-
-
American Diabetes Association1
-
5
-
-
0036783237
-
Fasting and postchallenge glycemia and cardiovascular disease risk: The framingham offspring study
-
Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002;25:1845-50.
-
(2002)
Diabetes Care
, vol.25
, pp. 1845-1850
-
-
Meigs, J.B.1
Nathan, D.M.2
D'Agostino, R.B.3
Wilson, P.W.4
-
6
-
-
0026768593
-
Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body
-
Yamanouchi T, Tachibana Y, Akanuma H, Minoda S, Shinohara T, Moromizato H, et al. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. Am J Physiol 1992;263: E268-73.
-
(1992)
Am J Physiol
, vol.263
, pp. E268-E273
-
-
Yamanouchi, T.1
Tachibana, Y.2
Akanuma, H.3
Minoda, S.4
Shinohara, T.5
Moromizato, H.6
-
7
-
-
0027984450
-
Serum 1,5- anhydroglucitol (1,5 ag): New clinical marker for glycemic control
-
Yamanouchi T, Akanuma Y. Serum 1,5- anhydroglucitol (1,5 ag): new clinical marker for glycemic control. Diabetes Res Clin Pract 1994; 24(Suppl):S261-8.
-
(1994)
Diabetes Res Clin Pract
, vol.24
, pp. S261-S268
-
-
Yamanouchi, T.1
Akanuma, Y.2
-
8
-
-
38149030947
-
1,5-anhydroglucitol (glycomark) as a marker of short-term glycemic control and glycemic excursions
-
Dungan KM. 1,5-anhydroglucitol (glycomark) as a marker of short-term glycemic control and glycemic excursions. Expert Rev Mol Diagn 2008; 8:9-19.
-
(2008)
Expert Rev Mol Diagn
, vol.8
, pp. 9-19
-
-
Dungan, K.M.1
-
9
-
-
0029941887
-
Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control
-
Yamanouchi T, Ogata N, Tagaya T, Kawasaki T, Sekino N, Funato H, et al. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet 1996;347:1514-8.
-
(1996)
Lancet
, vol.347
, pp. 1514-1518
-
-
Yamanouchi, T.1
Ogata, N.2
Tagaya, T.3
Kawasaki, T.4
Sekino, N.5
Funato, H.6
-
10
-
-
0024591825
-
The atherosclerosis risk in communities (aric) study: Design and objectives. The aric investigators
-
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989;129:687-702.
-
(1989)
Am J Epidemiol
, vol.129
, pp. 687-702
-
-
-
11
-
-
79952229368
-
Racial differences in glycemic markers: A cross-sectional analysis of community-based data
-
Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med 2011; 154:303-9.
-
(2011)
Ann Intern Med
, vol.154
, pp. 303-309
-
-
Selvin, E.1
Steffes, M.W.2
Ballantyne, C.M.3
Hoogeveen, R.C.4
Coresh, J.5
Brancati, F.L.6
-
12
-
-
79951726391
-
Comparison of two assays for serum 1,5-anhydroglucitol
-
Selvin E, Rynders GP, Steffes MW. Comparison of two assays for serum 1,5-anhydroglucitol. Clin Chim Acta 2011;412:793-5.
-
(2011)
Clin Chim Acta
, vol.412
, pp. 793-795
-
-
Selvin, E.1
Rynders, G.P.2
Steffes, M.W.3
-
13
-
-
0033503919
-
Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study
-
Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999;106:2269-80.
-
(1999)
Ophthalmology
, vol.106
, pp. 2269-2280
-
-
Hubbard, L.D.1
Brothers, R.J.2
King, W.N.3
Clegg, L.X.4
Klein, R.5
Cooper, L.S.6
-
14
-
-
0036141656
-
Reliability of retinal photography in the assessment of retinal microvascular characteristics: The atherosclerosis risk in communities study
-
Couper DJ, Klein R, Hubbard LD, Wong TY, Sorlie PD, Cooper LS, et al. Reliability of retinal photography in the assessment of retinal microvascular characteristics: the Atherosclerosis Risk in Communities Study. Am J Ophthalmol 2002;133: 78-88.
-
(2002)
Am J Ophthalmol
, vol.133
, pp. 78-88
-
-
Couper, D.J.1
Klein, R.2
Hubbard, L.D.3
Wong, T.Y.4
Sorlie, P.D.5
Cooper, L.S.6
-
15
-
-
39649088467
-
Relation between fasting glucose and retinopathy for diagnosis of diabetes: Three population-based cross-sectional studies
-
Wong TY, Liew G, Tapp RJ, Schmidt MI, Wang JJ, Mitchell P, et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008;371:736-43.
-
(2008)
Lancet
, vol.371
, pp. 736-743
-
-
Wong, T.Y.1
Liew, G.2
Tapp, R.J.3
Schmidt, M.I.4
Wang, J.J.5
Mitchell, P.6
-
16
-
-
84905115537
-
Identification of incident ckd stage 3 in research studies
-
Grams ME, Rebholz CM, McMahon B, Whelton S, Ballew SH, Selvin E, et al. Identification of incident CKD stage 3 in research studies. Am J Kidney Dis 2014;64:214-21.
-
(2014)
Am J Kidney Dis
, vol.64
, pp. 214-221
-
-
Grams, M.E.1
Rebholz, C.M.2
McMahon, B.3
Whelton, S.4
Ballew, S.H.5
Selvin, E.6
-
17
-
-
0038691972
-
Low-grade systemic inflammation and the development of type 2 diabetes: The atherosclerosis risk in communities study
-
Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 2003;52:1799-805.
-
(2003)
Diabetes
, vol.52
, pp. 1799-1805
-
-
Duncan, B.B.1
Schmidt, M.I.2
Pankow, J.S.3
Ballantyne, C.M.4
Couper, D.5
Vigo, A.6
-
18
-
-
77953464602
-
Measurement of hba1c from stored whole blood samples in the atherosclerosis risk in communities study
-
Selvin E, Coresh J, Zhu H, Folsom A, Steffes MW. Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study. J Diabetes 2010;2:118-24.
-
(2010)
J Diabetes
, vol.2
, pp. 118-124
-
-
Selvin, E.1
Coresh, J.2
Zhu, H.3
Folsom, A.4
Steffes, M.W.5
-
19
-
-
0020539888
-
Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency
-
Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-80.
-
(1983)
Clin Chem
, vol.29
, pp. 1075-1080
-
-
Siedel, J.1
Hagele, E.O.2
Ziegenhorn, J.3
Wahlefeld, A.W.4
-
20
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
-
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18: 499-502.
-
(1972)
Clin Chem
, vol.18
, pp. 499-502
-
-
Friedewald, W.T.1
Levy, R.I.2
Fredrickson, D.S.3
-
21
-
-
84941843774
-
Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency
-
Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 1984;22:165-74.
-
(1984)
J Clin Chem Clin Biochem
, vol.22
, pp. 165-174
-
-
Nagele, U.1
Hagele, E.O.2
Sauer, G.3
Wiedemann, E.4
Lehmann, P.5
Wahlefeld, A.W.6
Gruber, W.7
-
22
-
-
4244105186
-
-
Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina;
-
National Heart, Lung, and Blood Institute, Atherosclerosis Risk in Communities (ARIC) Study. Operations manual no. 10: clinical chemistry determinations, version 1.0. Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.
-
(1987)
Operations Manual No. 10: Clinical Chemistry Determinations, Version 1.0
-
-
National Heart, Lung, and Blood Institute, Atherosclerosis Risk in Communities (ARIC) Study,1
-
23
-
-
4243712397
-
-
Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina;
-
National Heart, Lung, and Blood Institute, Atherosclerosis Risk in Communities (ARIC) Study. Operations manual no. 2: cohort component procedures, version 1.0. Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.
-
(1987)
Operations Manual No. 2: Cohort Component Procedures, Version 1.0
-
-
National Heart, Lung, and Blood Institute, Atherosclerosis Risk in Communities (ARIC) Study,1
-
24
-
-
4244137130
-
-
Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina;
-
National Heart, Lung, and Blood Institute, Atherosclerosis Risk in Communities (ARIC) Study. Operations manual no. 11: sitting blood pressure, version 1.0. Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.
-
(1987)
Operations Manual No. 11: Sitting Blood Pressure, Version 1.0
-
-
National Heart, Lung, and Blood Institute, Atherosclerosis Risk in Communities (ARIC) Study,1
-
25
-
-
0020417197
-
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
-
Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-42.
-
(1982)
Am J Clin Nutr
, vol.36
, pp. 936-942
-
-
Baecke, J.A.1
Burema, J.2
Frijters, J.E.3
-
27
-
-
0030069896
-
Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
-
Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-87.
-
(1996)
Stat Med
, vol.15
, pp. 361-387
-
-
Harrell, F.E.1
Lee, K.L.2
Mark, D.B.3
-
28
-
-
78649477601
-
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
-
Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21.
-
(2011)
Stat Med
, vol.30
, pp. 11-21
-
-
Pencina, M.J.1
D'Agostino, R.B.2
Steyerberg, E.W.3
-
29
-
-
84870321341
-
Associations of alternative markers of glycemia with hemoglobin a(1c) and fasting glucose
-
Juraschek SP, Steffes MW, Selvin E. Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose. Clin Chem 2012;58:1648-55.
-
(2012)
Clin Chem
, vol.58
, pp. 1648-1655
-
-
Juraschek, S.P.1
Steffes, M.W.2
Selvin, E.3
-
30
-
-
84899585626
-
Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: A prospective cohort analysis of the atherosclerosis risk in communities (aric) study
-
Selvin E, Rawlings AM, Grams M, Klein R, Sharrett AR, Steffes M, Coresh J. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diab Endocrinol 2014;2:279-88.
-
(2014)
Lancet Diab Endocrinol
, vol.2
, pp. 279-288
-
-
Selvin, E.1
Rawlings, A.M.2
Grams, M.3
Klein, R.4
Sharrett, A.R.5
Steffes, M.6
Coresh, J.7
-
31
-
-
0029123496
-
1,5- anhydro-d-glucitol evaluates daily glycemic excursions in well-controlled niddm
-
Kishimoto M, Yamasaki Y, Kubota M, Arai K, Morishima T, Kawamori R, Kamada T. 1,5- Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM. Diabetes Care 1995;18:1156-9.
-
(1995)
Diabetes Care
, vol.18
, pp. 1156-1159
-
-
Kishimoto, M.1
Yamasaki, Y.2
Kubota, M.3
Arai, K.4
Morishima, T.5
Kawamori, R.6
Kamada, T.7
-
32
-
-
84860897474
-
A study on the association of serum 1,5- anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in china
-
Wang Y, Zhang YL, Wang YP, Lei CH, Sun ZL. A study on the association of serum 1,5- anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China. Diabetes Metab Res Rev 2012;28:357-62.
-
(2012)
Diabetes Metab Res Rev
, vol.28
, pp. 357-362
-
-
Wang, Y.1
Zhang, Y.L.2
Wang, Y.P.3
Lei, C.H.4
Sun, Z.L.5
-
33
-
-
79251631302
-
Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests
-
Goto M, Yamamoto-Honda R, Shimbo T, Goto A, Terauchi Y, Kanazawa Y, Noda M. Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests. Endocr J 2011; 58:13-7.
-
(2011)
Endocr J
, vol.58
, pp. 13-17
-
-
Goto, M.1
Yamamoto-Honda, R.2
Shimbo, T.3
Goto, A.4
Terauchi, Y.5
Kanazawa, Y.6
Noda, M.7
-
34
-
-
84865113079
-
Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in type 2 diabetes
-
Kim WJ, Park CY, Park SE, Rhee EJ, Lee WY, Oh KW, et al. Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in type 2 diabetes. Diabet Med 2012;29:1184-90.
-
(2012)
Diabet Med
, vol.29
, pp. 1184-1190
-
-
Kim, W.J.1
Park, C.Y.2
Park, S.E.3
Rhee, E.J.4
Lee, W.Y.5
Oh, K.W.6
-
35
-
-
79956218321
-
Nontraditional markers of glycemia: Associations with microvascular conditions
-
Selvin E, Francis LM, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL, Steffes MW. Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care 2011; 34:960-7.
-
(2011)
Diabetes Care
, vol.34
, pp. 960-967
-
-
Selvin, E.1
Francis, L.M.2
Ballantyne, C.M.3
Hoogeveen, R.C.4
Coresh, J.5
Brancati, F.L.6
Steffes, M.W.7
-
36
-
-
79958016689
-
Serum 1,5-anhydro-dglucitol levels predict first-ever cardiovascular disease: An 11-year population-based cohort study in Japan, the suita study
-
Watanabe M, Kokubo Y, Higashiyama A, Ono Y, Miyamoto Y, Okamura T. Serum 1,5-anhydro-Dglucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study. Atherosclerosis 2011;216:477-83.
-
(2011)
Atherosclerosis
, vol.216
, pp. 477-483
-
-
Watanabe, M.1
Kokubo, Y.2
Higashiyama, A.3
Ono, Y.4
Miyamoto, Y.5
Okamura, T.6
|